SYNERGY™

Everolimus-Eluting Platinum Chromium Coronary Stent System

A Meaningful Step Forward in Stent Technology

The SYNERGY BP Stent is the first and only FDA-approved drug-eluting stent with abluminal bioabsorbable polymer coating available in the U.S. It was designed to address the challenges associated with permanent polymer stents such as inflammation, neoatherosclerosis and late stent thrombosis.

The SYNERGY BP Stent provides synchronous drug elution and polymer absorption; the polymer is absorbed shortly after the drug elution is complete at 3-months, providing rapid healing and freedom from long-term polymer exposure. Learn more

Watch Video: Elderly Patients, Shortened DAPT, and SYNERGY™ BP Stent

The SENIOR Trial, presented at TCT 2017, reported superior outcomes with the SYNERGY BP Stent compared to a bare metal stent in the treatment of elderly patients with short DAPT duration (1 month in stable patients and 6 months in patients with ACS). Watch Prof. Olivier Varenne, PI of the SENIOR Trial, discuss the outcomes of this trial and implications the role SYNERGY BP Stent may have relative to shortened DAPT therapy.
Elderly Patients, Shortened DAPT, and SYNERGY™ BP Stent
 
Early Healing

Early Healing

Advanced design for optimal healing

Button
Clinical Outcomes

Clinical Outcomes

Outstanding evidence across trials

Button
Efficiency

Efficiency

How design impacts economic value

Button
Top